Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adenosine receptor antagonists: Recent advances and therapeutic perspective
Anjali Saini, Rajiv Patel, Sobhi Gaba, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113907-113907
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson’s Disease
Akihisa Mori, Jiang‐Fan Chen, Shinichi Uchida, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2366-2366
Open Access | Times Cited: 36
New paradigms in purinergic receptor ligand discovery
Kenneth A. Jacobson, Balaram Pradhan, Zhiwei Wen, et al.
Neuropharmacology (2023) Vol. 230, pp. 109503-109503
Open Access | Times Cited: 17
Pharmacology of Adenosine Receptors: Recent Advancements
Fabrizio Vincenzi, Silvia Pasquini, Chiara Contri, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1387-1387
Open Access | Times Cited: 16
Cryo-EM structure of the human adenosine A 2B receptor–G s signaling complex
Ying Chen, Jinyi Zhang, Yuan Weng, et al.
Science Advances (2022) Vol. 8, Iss. 51
Open Access | Times Cited: 25
The chronological evolution of fluorescent GPCR probes for bioimaging
Yingxu Wu, Boyu Zhang, Hu Xu, et al.
Coordination Chemistry Reviews (2023) Vol. 480, pp. 215040-215040
Closed Access | Times Cited: 13
Optical Control of Adenosine A2A Receptor Using Istradefylline Photosensitivity
Anaëlle Dumazer, Xavier Gómez‐Santacana, Fanny Malhaire, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 3, pp. 645-655
Open Access | Times Cited: 5
The role of caffeine in headache disorders
Andrew Charles
Current Opinion in Neurology (2024) Vol. 37, Iss. 3, pp. 289-294
Closed Access | Times Cited: 5
Inhibition of ADORA3 promotes microglial phagocytosis and alleviates chronic ischemic white matter injury
Yuhao Xu, Limoran Tang, Chao Zhou, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 5
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 708-708
Open Access | Times Cited: 5
General structure-activity relationship models for the inhibitors of Adenosine receptors: A machine learning approach
Mona Janbozorgi, Sara Kaveh, M. S. Neiband, et al.
Molecular Diversity (2025)
Closed Access
Treatment of Motor Symptoms of Parkinson’s Disease
Luca Marsili, Matteo Bologna, Lily Y. Chen, et al.
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 341-363
Closed Access
Longitudinal Effects of Lifetime Caffeine Consumption on Levels of Depression, Anxiety, and Stress: A Comprehensive Review
Sena Ünsal, Nevin Şanlıer
Current Nutrition Reports (2025) Vol. 14, Iss. 1
Open Access
The literature of heterocyclic chemistry, part XXII, 2022
Галина А. Газиева, Yu. B. Evdokimenkova, N. O. Soboleva
Advances in heterocyclic chemistry (2025)
Closed Access
Inhibition of Adora3 Acceletaes Hematoma Resolution and Neurological Recovery after Ich
Yu Qi, Xian Yu, Yirui Kuang, et al.
(2025)
Closed Access
Microglial Phagocytosis and Regulatory Mechanisms: Key Players in the Pathophysiology of Depression
Man Wang, G. L. Jin, Tingting Duan, et al.
Neuropharmacology (2025) Vol. 271, pp. 110383-110383
Closed Access
Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer’s Disease
Stefania Merighi, Pier Andrea Borea, Katia Varani, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2680-2680
Open Access | Times Cited: 21
Chalcones as Potential Ligands for the Treatment of Parkinson’s Disease
Ewelina Królicka, Katarzyna Kieć‐Kononowicz, Dorota Łażewska
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 847-847
Open Access | Times Cited: 21
Targeting Immunosuppressive Adenosine Signaling: A Review of Potential Immunotherapy Combination Strategies
David J. Zahavi, James W. Hodge
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8871-8871
Open Access | Times Cited: 12
Small molecule inhibitors for cancer immunotherapy and associated biomarkers – the current status
Lisa Schlicher, Luke G. Green, Andrea Romagnani, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Regulatory T cell-derived exosome mediated macrophages polarization for osteogenic differentiation in fracture repair
Tingting Wu, Lulu Wang, Jian Chen, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 266-282
Closed Access | Times Cited: 3
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
(2024)
Open Access | Times Cited: 3
Photoinduced Copper-Catalyzed Cross-Coupling of Acylsilanes with Azoles
Long Zheng, Yingchao Li, Yichen Wu, et al.
(2024)
Open Access | Times Cited: 2
Roadmap for the expression of canonical and extended endocannabinoid system receptors and metabolic enzymes in peripheral organs of preclinical animal models
Jose J. Rosado‐Franco, A. L. Ellison, Cory J. White, et al.
Physiological Reports (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 2
Adenine, a key player in biology and medicinal chemistry
Alexandra Fillion, Sophie Vichier‐Guerre, Paola B. Arimondo
Comptes Rendus Chimie (2024) Vol. 27, Iss. S2, pp. 143-160
Open Access | Times Cited: 2
Manual acupuncture ameliorates inflammatory pain by upregulating adenosine A3 receptor in complete Freund’s adjuvant-induced arthritis rats
Jingping Xu, Qian-Wen Ouyang, Mei-juan Shao, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112095-112095
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top